The upregulation of the complement pathway in the SPs suggests a systemic pro-inflammatory response induced by SARS-CoV-2 infection as documented before.33 Severe COVID-19 patients are normally associated with increased levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-α. This evidence concerns the gene TNF and COVID-19.